Dimensional Fund Advisors LP raised its stake in National Health Investors, Inc. (NYSE:NHI) by 8.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 542,845 shares of the real estate investment trust’s stock after buying an additional 43,890 shares during the period. Dimensional Fund Advisors LP owned about 1.36% of National Health Investors worth $39,426,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the company. Geode Capital Management LLC boosted its position in National Health Investors by 6.3% in the first quarter. Geode Capital Management LLC now owns 299,030 shares of the real estate investment trust’s stock valued at $21,718,000 after buying an additional 17,839 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its position in National Health Investors by 6.5% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 5,961 shares of the real estate investment trust’s stock valued at $433,000 after buying an additional 365 shares during the last quarter. Vanguard Group Inc. boosted its position in National Health Investors by 3.3% in the first quarter. Vanguard Group Inc. now owns 6,219,436 shares of the real estate investment trust’s stock valued at $451,717,000 after buying an additional 201,133 shares during the last quarter. Mackenzie Financial Corp boosted its position in National Health Investors by 69.9% in the first quarter. Mackenzie Financial Corp now owns 7,739 shares of the real estate investment trust’s stock valued at $562,000 after buying an additional 3,185 shares during the last quarter. Finally, Menta Capital LLC boosted its position in National Health Investors by 99.2% in the first quarter. Menta Capital LLC now owns 14,936 shares of the real estate investment trust’s stock valued at $1,085,000 after buying an additional 7,438 shares during the last quarter. 69.10% of the stock is owned by institutional investors.

National Health Investors, Inc. (NYSE NHI) traded down 0.62% on Friday, reaching $78.63. 180,659 shares of the company traded hands. The firm has a 50 day moving average of $77.28 and a 200-day moving average of $75.17. The stock has a market capitalization of $3.22 billion, a PE ratio of 20.19 and a beta of 0.56. National Health Investors, Inc. has a one year low of $66.31 and a one year high of $82.53.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing the Zacks’ consensus estimate of $1.29 by $0.36. The company had revenue of $69.84 million during the quarter, compared to analysts’ expectations of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. National Health Investors’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same period last year, the firm earned $1.22 earnings per share. On average, analysts anticipate that National Health Investors, Inc. will post $3.88 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 10th. Shareholders of record on Friday, September 29th will be paid a $0.95 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.80 dividend on an annualized basis and a yield of 4.83%. National Health Investors’s dividend payout ratio (DPR) is currently 97.69%.

WARNING: “National Health Investors, Inc. (NYSE:NHI) Stake Raised by Dimensional Fund Advisors LP” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/19/dimensional-fund-advisors-lp-purchases-43890-shares-of-national-health-investors-inc-nysenhi-updated-updated-updated.html.

NHI has been the subject of a number of recent research reports. BidaskClub upgraded shares of National Health Investors from a “sell” rating to a “hold” rating in a research note on Thursday. Zacks Investment Research upgraded shares of National Health Investors from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th. ValuEngine cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. Mizuho reiterated a “neutral” rating on shares of National Health Investors in a research report on Wednesday, June 28th. Finally, Stifel Nicolaus increased their target price on shares of National Health Investors from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Wednesday, June 21st. One analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $79.60.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.